FDAnews
www.fdanews.com/articles/202064-grifols-earns-ce-marks-for-hivhepatitis-and-babesia-parasite-blood-tests
CE mark

Grifols Earns CE Marks for HIV/Hepatitis and Babesia Parasite Blood Tests

March 29, 2021

Grifols has received CE mark certifications for its Procleix UltrioPlex E and Procleix Babesia assays.

The Procleix UltrioPlex E, a nucleic acid test, uses a single sample of serum or plasma to simultaneously detect the presence of HIV-1, HIV-2, hepatitis B, hepatitis C and hepatitis E. The Procleix Babesia Assay detects Babesia, a tick-borne parasite that can be spread through blood transfusions, using a whole blood specimen.

The tests will soon become available in European markets, enabling blood banks to improve the safety of transfusions, the company said.

View today's stories